Novosense groundbreaking ECG technology
Novosense's first line of products is
the CardioSenseSystem®. The system is designed to replace
stationary ECG equipment as well as portable ECG systems used in hospital
intensive care units.
The system is
designed for low-cost, high-quality ECG monitoring. The CardioSenseSystem®
includes disposable ECG registration and transmission units, a receiving unit
called CardioBase® and a back-end system for presentation, storage and
processing of ECG information.
The
basic idea is to measure ECGs completely wirelessly with low-cost disposable
units in the same way as today’s wired disposable electrodes. The
difference is that no wires have to be connected, thus eliminating
the problems with electrodes or wires coming lose. Novosense's
patented ECG measurement technology makes it possible to measure all forms
of ECG with disposable self-contained units called CardioPatch®, no
larger than 4 cm in diameter.
CardioPatch®
The
CardioPatch® sensor is applied to the body with an adhesive and looks much like a traditional ECG electrode. In contrast the CardioPatch® is
a fully integrated unit containing electrodes, ECG amplifier, a radio
transmitter and means of identification. The electrodes on the patch are
the wet-gel standard type used for ECG measurements. The electrodes are
connected to unique and patented measurement electronics. CardioPatch®
transmits the ECG signal 24 hours to the CardioBase® receiver.
The
CardioBase® has a high processing capability. Advanced signal processing
is used to ensure secure and accurate transmission of the ECG signals.
Different frequency bands can be used according to the regulations in different
markets.
CardioPatch® will be manufactured with a unique processing technology,
allowing volume production at low cost. Novosense holds the rights to use
the processing technology developed and patented by Acreo AB.
|
